- Trials with a EudraCT protocol (312)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
312 result(s) found for: Balance.
Displaying page 1 of 16.
EudraCT Number: 2004-002108-14 | Sponsor Protocol Number: PD-BLS-01-EU | Start Date*: 2005-06-22 |
Sponsor Name:Fresenius Medical Care Deutschland GmbH. | ||
Full Title: Multizentrische Studie mit einer Niedrig-Natrium Peritonealdialyse-Lösung bei hypertensiven od. antihypertensiv behandelten CAPD Patienten auf balance Lösung | ||
Medical condition: | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-000562-21 | Sponsor Protocol Number: L00014 CP 201 | Start Date*: 2007-09-19 | |||||||||||
Sponsor Name:PIERRE FABRE MEDICAMENT - IDPF | |||||||||||||
Full Title: Effects of TANGANIL (three 500 mg tablets twice daily) on postural disturbances in the elderly. | |||||||||||||
Medical condition: Postural disturbances in the elderly | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001545-25 | Sponsor Protocol Number: CHDR1409 | Start Date*: 2014-07-02 | ||||||||||||||||
Sponsor Name:Centre for Human Drug Research | ||||||||||||||||||
Full Title: Randomized, double-blind, placebo-controlled, three way crossover, double dummy, single centre study evaluating the effect of haloperidol 2 mg and lorazepam 1 mg on posturography and underlying sys... | ||||||||||||||||||
Medical condition: Healthy volunteers (balance disorders) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004176-22 | Sponsor Protocol Number: IMPURE-Study | Start Date*: 2017-04-28 |
Sponsor Name:Medizinische Universität Graz | ||
Full Title: IMProving Ultrafiltration and REmoval of uremic toxins by adapted automated peritoneal dialysis in a single center study (IMPURE-Study). | ||
Medical condition: Chronic kidney disease G5D | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-003184-11 | Sponsor Protocol Number: R0002820 | Start Date*: 2016-01-04 |
Sponsor Name:Radboud University Medical Centre | ||
Full Title: Functional effects of botulinum toxin in the hip adductors and subsequent exercise in patients with hereditary spastic paraplegia: a pilot RCT | ||
Medical condition: Hereditary Spastic Paraplegia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-005324-17 | Sponsor Protocol Number: JH01 | Start Date*: 2007-04-13 |
Sponsor Name:Sint Maartenskliniek | ||
Full Title: Influence of indometacin on reaction time, postural balance and obstacle avoidance in healthy subjects. | ||
Medical condition: Healthy volunteers trial with registered NSAID. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003365-99 | Sponsor Protocol Number: NL62809.068.17 | Start Date*: 2017-11-08 |
Sponsor Name:Maastricht University | ||
Full Title: The effects of ceasing opioid, benzodiazepine, or Z-hypnotic drug use on measures of driving performance and postural balance. | ||
Medical condition: Insomnia, Anxiety, chronic pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002568-18 | Sponsor Protocol Number: 5B | Start Date*: 2015-07-15 |
Sponsor Name:Stockholm County Council, Karolinska University Hospital Huddinge, Department of Anesthesiology and Intensive Care | ||
Full Title: Albumin mass balance and kinetics in liver transplantation. An open exploratory pilot study | ||
Medical condition: liver transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001104-41 | Sponsor Protocol Number: ALXN1840-WD-204 | Start Date*: 2020-07-22 | |||||||||||
Sponsor Name:Alexion Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2, open-label study to assess copper and molybdenum balance in participants with Wilson disease treated with ALXN1840 | |||||||||||||
Medical condition: Wilson Disease (WD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002011-61 | Sponsor Protocol Number: 77267 | Start Date*: 2021-08-13 |
Sponsor Name:Academisch ziekenhuis Maastricht | ||
Full Title: The glutamate/GABA balance as novel therapeutic target for psychotic and cognitive symptoms in 22q11.2 deletion syndrome | ||
Medical condition: 22q11.2 deletion syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004627-20 | Sponsor Protocol Number: 176S11NB | Start Date*: 2013-04-05 | |||||||||||
Sponsor Name:Pascoe pharmazeutische Präparate GmbH | |||||||||||||
Full Title: Randomized double-blind, placebo controlled study with NEURAPAS® balance in addition to psychoeducation or psychotherapy in adolescents from 12 to 17 years suffering from mild depressive episodes w... | |||||||||||||
Medical condition: Mild depressive episodes with nervous restlessness | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005129-99 | Sponsor Protocol Number: TA799-013 | Start Date*: 2021-02-10 | |||||||||||
Sponsor Name:VectivBio AG | |||||||||||||
Full Title: A multicenter, open-label, metabolic balance study to evaluate the effects of apraglutide on intestinal absorption in adult subjects with short bowel syndrome, intestinal failure (SBS-IF), and colo... | |||||||||||||
Medical condition: short bowel syndrome, intestinal failure (SBS-IF), colon-in-continuity (CIC) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) BE (Completed) DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003781-42 | Sponsor Protocol Number: 17465 | Start Date*: 2005-09-21 |
Sponsor Name:University of Dundee | ||
Full Title: | ||
Medical condition: Transient hypothyroxinanaemia | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002404-42 | Sponsor Protocol Number: 17465 | Start Date*: 2005-08-18 |
Sponsor Name:University of Dundee | ||
Full Title: A pilot study to inform a randomised controlled trial of iodine supplementation in preterm infants | ||
Medical condition: transient hypothyroxinaemia | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004466-34 | Sponsor Protocol Number: 005,1 | Start Date*: 2014-02-25 |
Sponsor Name:Hyks Silmätautien klinikka | ||
Full Title: The effect of hypertonic saline on blood electrolytes, acid-base balance and hormones that regulate blood pressure | ||
Medical condition: Elevated intraocular pressure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-005734-18 | Sponsor Protocol Number: VOLU-011-CP4 | Start Date*: 2012-07-23 |
Sponsor Name:Fresenius Kabi Deutschland GmbH | ||
Full Title: Prospective randomised controlled open-label explorative multi-centre pilot trial of Volulyte®-supplemented versus Albumin-supplemented fluid resuscitation for major burns | ||
Medical condition: patients with major burns | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-012073-34 | Sponsor Protocol Number: R0000063 | Start Date*: 2009-07-08 | |||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | |||||||||||||
Full Title: Botulinum toxin for treating calf muscle spasticity in Hereditary Spastic Paraparesis (HSP): functional effects on dynamic balance and gait | |||||||||||||
Medical condition: Subjects with hereditary spastic paraparesis (HSP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001762-13 | Sponsor Protocol Number: sepsis 1 | Start Date*: 2005-07-13 |
Sponsor Name:Universitätskinderklinik Heidelberg | ||
Full Title: Energy metabolism of critically ill children treated with lipid emulsion and carnitine | ||
Medical condition: The primary purpose of the study is an examination of the ability of lipid emulsions and carnitin supplementation to reduce the morbidity associated with sepsis and catabolic conditions by altering... | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-001317-15 | Sponsor Protocol Number: BAL2-2006 | Start Date*: 2006-05-09 |
Sponsor Name:University of Oxford | ||
Full Title: BALANCE 2: Bipolar disorder:Antidepressant/Lamotrigine/ANtipsychotic Comparative Evaluation | ||
Medical condition: Bipolar depression. | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-002487-41 | Sponsor Protocol Number: GLY-321-2017 | Start Date*: 2018-01-31 | |||||||||||
Sponsor Name:GLyPharma Therapeutic Inc. (a wholly owned subsidiary of VectivBio Holding AG) | |||||||||||||
Full Title: A Phase Ib/IIa open-label, repeated dose, metabolic balance study of FE 203799 in patients with short bowel syndrome | |||||||||||||
Medical condition: Short bowel syndrome (SBS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
